Exit Notice
You are about to leave ClinicalTrials.gov and go to: Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531 URL: https://pubmed.ncbi.nlm.nih.gov/31386611/
Click on the link to continue or return to ClinicalTrials.gov Home